1. Home
  2. ACOG vs QMLS Comparison

ACOG vs QMLS Comparison

Compare ACOG & QMLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha Cognition Inc.

ACOG

Alpha Cognition Inc.

N/A

Current Price

$9.56

Market Cap

193.6M

Sector

N/A

ML Signal

N/A

QMLS

QumulusAI Inc. Common Stock

N/A

Current Price

$6.28

Market Cap

210.4M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
ACOG
QMLS
Founded
2000
N/A
Country
Canada
United States
Employees
N/A
N/A
Industry
EDP Services
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
193.6M
210.4M
IPO Year
2024
2025

Fundamental Metrics

Financial Performance
Metric
ACOG
QMLS
Price
$9.56
$6.28
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$16.00
N/A
AVG Volume (30 Days)
130.6K
320.0K
Earning Date
05-14-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
41.58
N/A
EPS
N/A
N/A
Revenue
$10,220,275.00
N/A
Revenue This Year
$139.22
N/A
Revenue Next Year
$134.48
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.50
$5.31
52 Week High
$10.14
$14.82

Technical Indicators

Market Signals
Indicator
ACOG
QMLS
Relative Strength Index (RSI) 65.52 30.95
Support Level $5.28 $5.49
Resistance Level N/A $7.95
Average True Range (ATR) 0.66 0.74
MACD 0.06 0.21
Stochastic Oscillator 78.87 29.81

Price Performance

Historical Comparison
ACOG
QMLS

About ACOG Alpha Cognition Inc.

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

About QMLS QumulusAI Inc. Common Stock

QumulusAI Inc is a cloud infrastructure company engaged in the rapid deployment of graphics processing unit (GPU)-powered solutions for artificial intelligence (AI) applications, serving a critical market that is often overlooked by large-scale cloud providers (hyperscalers), which operate massive, standardized computing infrastructures serving the immense enterprises. The platform delivers flexible, competitively priced, and customizable solutions for underserved small- and mid-market customers, including machine learning teams, AI infrastructure startups, and research institutions, and also supports the scale and complexity requirements of large enterprises. Its products are B300 SXM6, B200 SXM, RTX Pro 6000, H200 SXM, and Others. Its solutions are Enterprise, Research, and AI Startups.

Share on Social Networks: